関連する実験動画
Updated: Feb 13, 2026

07:11
Laser Micro-Irradiation to Study DNA Recruitment During S Phase
Published on: April 16, 2021
4.9K
臨床試験の半ばに投与量レベルを挿入するための新しい方法 初期段階の腫瘍学の組み合わせ研究
Matthew George1, Ian Wadsworth1, Pavel Mozgunov2
1Phastar, London, UK.
Statistics in medicine
|February 12, 2026
まとめ
この研究は,腫瘍学試験の初期段階で用量レベルを挿入するための新しい方法を導入しています. 毒性の輪郭を特定し,試験効率を改善することによって,最大許容量の組み合わせを見つけるのに役立ちます.
科学分野:
- 腫瘍学 腫瘍学
- クリニック・トライアル 臨床試験
- バイオ統計学 バイオ統計学
背景:
- 組み合わせ治療は,早期腫瘍学試験においてますます使用されています.
- 最大許容量 (MTD) の組み合わせを特定することは,重要な目標です.
- 課題は,初期用量セットには,標的毒性に近い組み合わせが欠如しているときに発生します.
研究 の 目的:
- 初期段階の腫瘍学研究における試験半ばの用量レベルを挿入するための新しい方法を提案する.
- 初期セットが最適でない場合にMTDの組み合わせを見つけるという課題に取り組むために.
- 投与量決定試験におけるMTD識別の精度を向上させるため.
主な方法:
- ドススペースを分割する毒性コントールの検索方法を開発した.
- コントールは,標的値の上下にある毒性の組み合わせを識別します.
- この方法は,いずれの組み合わせも標的毒性に近づいていない場合に,用量レベルの挿入を誘発します.
- PIPE設計と2Dベイジアン論理回帰モデル (BLRM) のシミュレーションを使用してアプローチを評価しました.
主要な成果:
- 提案された挿入方法は,標的毒性に近い組み合わせを選択する確率を高めます.
- この方法は,サブセラピ的または有毒な用量を推奨する確率を高めることはありません.
- シミュレーション結果は,新しいアプローチの有効性を実証しています.
結論:
- 新しく開発されたミッド・トライアル・ドース・インセプション・メソッドは,腫瘍学試験におけるMTDの発見に対して,体系的な解決策を提供します.
- このアプローチは,最適な用量組み合わせを特定する能力を高め,試験の成功率を改善します.
- この方法は,さまざまなモデルベースおよびモデルアシスト設計と互換性があります.
関連する概念動画
Dose Size and Dosing Frequency: Determination Methods
328
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
328
Introduction and Methods of Leveling
534
Leveling is a surveying procedure used to determine elevation differences between distant points. Elevation refers to the vertical distance above or below a reference datum, typically mean sea level (MSL). In the United States, elevations are often referenced to the mean sea level station at Father Point Rimouski along the St. Lawrence Seaway. To make the datum accessible, permanent markers are established throughout the region. These markers, called benchmarks, have known elevations. If the...
534
Bioavailability Study Design: Single Versus Multiple Dose Studies
251
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
251
IV Infusion to Oral Dosing: Conversion Methods
2
The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
2
Trial and Error and Algorithm
429
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429
Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K

